Pathology Industry in the United Kingdom Market Research & Statistics

24/7 Customer Support

Talk to Sam

+1 718 473 0872

All regions

About 3 300 reports

Download Unlimited Documents from Trusted Public Sources

Pathology Description in the UK

  • December 2014
    32 pages
  • Cancer  

  • United Kingdom  

    Europe  

View report >

Pathology Description in the UK

  • December 2014
    27 pages
  • Cancer  

  • United Kingdom  

    Europe  

View report >

Pathology Description in the UK

  • December 2014
    6 pages
  • Pathology  

    Diabete  

  • United Kingdom  

View report >

Pathology Description in the UK, Weekly Update

  • December 2014
    10 pages
  • Influenza  

  • United Kingdom  

    Europe  

View report >

Pathology Description in the UK - Forecast

  • December 2014
    63 pages
  • Mental Illness  

  • United Kingdom  

    Europe  

View report >

Pathology Description in the UK

  • December 2014
    90 pages
  • Cancer  

  • United Kingdom  

View report >

Pathology Description in the UK - Forecast

  • December 2014
    12 pages
  • Hepatitis B  

  • United Kingdom  

View report >

Pathology Description in the UK

  • December 2014
    23 pages
  • Stroke  

  • United Kingdom  

View report >

Pathology Description in the UK - Forecast, Weekly Update

  • November 2014
    9 pages
  • Influenza  

  • United Kingdom  

    Europe  

View report >

Pathology Description in the UK - Forecast, Weekly Update

  • November 2014
    9 pages
  • Influenza  

    Infectious Dise...  

  • United Kingdom  

    Europe  

View report >

Search in Pathology Industry

About 300 reports

Purchase Reports From Reputable Market Research Publishers
(From $ 250 - $ 6 995)

PharmaPoint: HER2-Positive Breast Cancer - 5EU Drug Forecast and Market Analysis to 2023

PharmaPoint: HER2-Positive Breast Cancer - 5EU Drug Forecast and Market Analysis to 2023

  • $ 6 995
  • Industry report
  • September 2014
  • by Global Data

PharmaPoint: HER2-Positive Breast Cancer - 5EU Drug Forecast and Market Analysis to 2023 Summary HER2-positive breast cancer is the second most common cancer in the world and the most common cancer in ...

Epicast Report: Rheumatoid Arthritis - Epidemiology For ...

December 2014 $ 3 995

Herceptin (her2-positive Breast Cancer) - Forecast And ...

September 2014 $ 3 495

Perjeta (her2-positive Breast Cancer) - Forecast And Ma ...

September 2014 $ 3 495

Kadcyla (her2-positive Breast Cancer) - Forecast And Ma ...

September 2014 $ 3 495

Tykerb (her2-positive Breast Cancer) - Forecast And Mar ...

September 2014 $ 3 495

Neratinib (her2-positive Breast Cancer) - Forecast And ...

September 2014 $ 3 495

Eu: Hearing Aids (excl. Parts And Accessories) - Market ...

December 2014 $ 2 161

Brinzolamide - Patent, Extension And Data Exclusivity ...

October 2014 $ 653

Duloxetine - Patent, Extension And Data Exclusivity Ex ...

October 2014 $ 653


ReportLinker is an award-winning market research solution that finds, filters and organizes the latest industry data so you get all the market research you need - quickly, in one place.